Abstract

Chemokines are a small family of cytokines that were first discovered as chemotactic factors in leukocytes during inflammation, and reports on the relationship between chemokines and cancer progression have recently been increasing. The CCL2-CCR2 axis is one of the major chemokine signaling pathways, and has various functions in tumor progression, such as increasing tumor cell proliferation and invasiveness, and creating a tumor microenvironment through increased angiogenesis and recruitment of immunosuppressive cells. This review discusses the roles of the CCL2-CCR2 axis and the tumor microenvironment in cancer progression and their future roles in cancer therapy.

Highlights

  • Published: 8 August 2021The tumor microenvironment (TME) is an important factor in the growth and progression of cancer and comprises a wide variety of cells, including cancer cells, immune cells, stromal cells, and epithelial cells [1]

  • Chemokines have been widely reported in autoimmune-related diseases, but, in recent years, more reports have linked these to the control of cancer in the TME [3]

  • Chemokines induce cytotoxic T lymphocytes into tumor tissues and exhibit anticancer effects, they induce cells that suppress tumor immunity, such as the tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) [3,4]

Read more

Summary

Introduction

The tumor microenvironment (TME) is an important factor in the growth and progression of cancer and comprises a wide variety of cells, including cancer cells, immune cells, stromal cells, and epithelial cells [1]. Chemokines induce cytotoxic T lymphocytes into tumor tissues and exhibit anticancer effects, they induce cells that suppress tumor immunity, such as the tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) [3,4]. Among these chemokines, we report on CCL2, which has been shown to play essential roles in the TME, and its main receptor, CCR2

Basic Information of CCL2-CCR2 Axis
Relationship between the CCL2-CCR Axis and the Cells That Make Up the TME
CCL2 secreted by cancer cells orcells
Overview
Relationship between Malignant Tumors and CCL2-CCR2 Axis
Prostate Cancer
Breast Cancer
Lung Cancer
Kidney Cancer
Bladder Cancer
Colorectal Cancer
Other Cancers
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.